Rozanolixizumab: An Investigational Neonatal Fc Receptor (FcRn) for the Treatment of Generalized Myasthenia Gravis (gMG)
Event Type:
Webinars
Date:
Thursday, Mar. 9, 2023, 2–3pm ET
Member:
Free
Non-Member:
Free
